Intertumoral Heterogeneity within Medulloblastoma Subgroups

Cancer Cell

Volumn 31, Issue 6, 2017, Pages 737-754.e6

  Cavalli, Florence M G ^a   Remke, Marc ^b,c,ba   Rampasek, Ladislav ^a,d   Peacock, John ^a,c   Shih, David J H ^a,c   Luu, Betty ^a   Garzia, Livia ^a   Torchia, Jonathon ^a,c   Nor, Carolina ^a   Morrissy, A Sorana ^a   Agnihotri, Sameer ^e   Thompson, Yuan Yao ^a,c   Kuzan Fischer, Claudia M ^a   Farooq, Hamza ^a,c   Isaev, Keren ^c,f   Daniels, Craig ^a   Cho, Byung Kyu ^g   Kim, Seung Ki ^g   Wang, Kyu Chang ^g   Lee, Ji Yeoun ^g   Grajkowska, Wieslawa A ^h   Perek Polnik, Marta ^h   Vasiljevic, Alexandre ^i,bb   Faure Conter, Cecile ^j   Jouvet, Anne ^k   Giannini, Caterina ^l   Nageswara Rao, Amulya A ^l   Li, Kay Ka Wai ^m   Ng, Ho Keung ^m   Eberhart, Charles G ⁿ   Pollack, Ian F ^o   Hamilton, Ronald L ^o   Gillespie, G Yancey ^p   Olson, James M ^q,r   Leary, Sarah ^r   Weiss, William A ^s   Lach, Boleslaw ^t,bc   Chambless, Lola B ^u   Thompson, Reid C ^u   Cooper, Michael K ^u   Vibhakar, Rajeev ^v   Hauser, Peter ^w   van Veelen, Marie Lise C ^x   Kros, Johan M ^x   French, Pim J ^x   Ra, Young Shin ^y   Kumabe, Toshihiro ^z   López Aguilar, Enrique ^aa   Zitterbart, Karel ^ab   Sterba, Jaroslav ^ab   Finocchiaro, Gaetano ^ac   Massimino, Maura ^ad   Van Meir, Erwin G ^ae   Osuka, Satoru ^ae   Shofuda, Tomoko ^af   Klekner, Almos ^ag   Zollo, Massimo ^ah   Leonard, Jeffrey R ^ai   Rubin, Joshua B ^ai   Jabado, Nada ^aj   Albrecht, Steffen ^aj,bd   Mora, Jaume ^ak   Van Meter, Timothy E ^al   Jung, Shin ^am   Moore, Andrew S ^an,be   Hallahan, Andrew R ^an,be   Chan, Jennifer A ^ao   Tirapelli, Daniela P C ^ap   Carlotti, Carlos G ^ap   Fouladi, Maryam ^aq   Pimentel, José ^ar   Faria, Claudia C ^ar   Saad, Ali G ^as   Massimi, Luca ^at   Liau, Linda M ^au   Wheeler, Helen ^av   Nakamura, Hideo ^aw   Elbabaa, Samer K ^ax   Perezpeña Diazconti, Mario ^ay   Chico Ponce de León, Fernando ^ay   Robinson, Shenandoah ^az   Zapotocky, Michal ^a   Lassaletta, Alvaro ^a   Huang, Annie ^a   Hawkins, Cynthia E ^a   Tabori, Uri ^a   Bouffet, Eric ^a   Bartels, Ute ^a   Dirks, Peter B ^a   Rutka, James T ^a,c   Bader, Gary D ^c,d,bf   Reimand, Jüri ^c,f   Goldenberg, Anna ^a,d   Ramaswamy, Vijay ^a   Taylor, Michael D ^a,c   more..

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^f ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^g Seoul National University Children's Hospital   (South Korea)

^h UNIVERSITY OF WARSAW   (Poland)

ⁱ HOSPICES CIVILS DE LYON   (France)

^j Institute of Pediatric Hematology and Oncology   (France)

^k UNIVERSITÉ DE LYON   (France)

^l MAYO CLINIC   (United States)

^m CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

ⁿ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^p Kentucky   (United States)

^q Fred Hutchinson Cancer Research Center   (United States)

^r UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t MCMASTER UNIVERSITY   (Canada)

^u VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^v Children's Hospital Colorado   (United States)

^w SEMMELWEIS UNIVERSITY   (Hungary)

^x ERASMUS MEDICAL CENTER   (Netherlands)

^y University of Ulsan   (South Korea)

^z KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^aa INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^ab MASARYK UNIVERSITY   (Czech Republic)

^ac DEPARTMENT OF NEUROSURGERY   (Italy)

^ad NATIONAL CANCER INSTITUTE   (Italy)

^ae EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^af OSAKA NATIONAL HOSPITAL   (Japan)

^ag UNIVERSITY OF DEBRECEN   (Hungary)

^ah UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^ai WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aj MCGILL UNIVERSITY   (Canada)

^ak HOSPITAL SANT JOAN DE DÉU   (Spain)

^al VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^am Chonnam National University   (South Korea)

^an UNIVERSITY OF QUEENSLAND   (Australia)

^ao UNIVERSITY OF CALGARY   (Canada)

^ap UNIVERSITY OF SÃO PAULO   (Brazil)

^aq UNIVERSITY OF CINCINNATI   (United States)

^ar HOSPITAL DE SANTA MARIA   (Portugal)

^as UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^at CATHOLIC UNIVERSITY   (Italy)

^au UNIVERSITY OF CALIFORNIA   (United States)

^av UNIVERSITY OF SYDNEY   (Australia)

^aw KUMAMOTO UNIVERSITY   (Japan)

^ax SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ay HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^az CASE WESTERN RESERVE UNIVERSITY   (United States)

^ba GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^bb LYON NEUROSCIENCE RESEARCH CENTER   (France)

^bc HAMILTON GENERAL HOSPITAL   (Canada)

^bd MONTREAL CHILDREN S HOSPITAL   (Canada)

^be LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^bf MOUNT SINAI HOSPITAL   (Canada)

more..

Author keywords

copy number; gene expression; integrative clustering; medulloblastoma; methylation; subgroups

Indexed keywords

CYCLIN DEPENDENT KINASE 6; FIBROBLAST GROWTH FACTOR RECEPTOR 1; PROTEIN; PROTEIN MYCN; PROTEIN P53; SONIC HEDGEHOG PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; CLINICAL OUTCOME; DNA METHYLATION; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; INTERTUMORAL HETEROGENEITY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; CLASSIFICATION; CLUSTER ANALYSIS; COHORT ANALYSIS; COPY NUMBER VARIATION; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; PERSONALIZED MEDICINE;

CLUSTER ANALYSIS; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MEDULLOBLASTOMA; PRECISION MEDICINE;

EID: 85020687117     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2017.05.005     Document Type: Article

References (45)

1. Aryee, M.J., Jaffe, A.E., Corrada-Bravo, H., Ladd-Acosta, C., Feinberg, A.P., Hansen, K.D., Irizarry, R.A., Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA Methylation microarrays. Bioinformatics 30 (2014), 1363–1369.
2. Brat, D.J., Verhaak, R.G., Aldape, K.D., Yung, W.K., Salama, S.R., Cooper, L.A., Rheinbay, E., Miller, C.R., Vitucci, M., Morozova, O., et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372 (2015), 2481–2498.
3. Cho, Y.-J., Tsherniak, A., Tamayo, P., Santagata, S., Ligon, A., Greulich, H., Berhoukim, R., Amani, V., Goumnerova, L., Eberhart, C.G., et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J. Clin. Oncol. 29 (2011), 1424–1430.
4. Collisson, E.A., Campbell, J.D., Brooks, A.N., Berger, A.H., Lee, W., Chmielecki, J., Beer, D.G., Cope, L., Creighton, C.J., Danilova, L., et al. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511 (2014), 543–550.
5. Dai, M., Wang, P., Boyd, A.D., Kostov, G., Athey, B., Jones, E.G., Bunney, W.E., Myers, R.M., Speed, T.P., Akil, H., et al. Evolving gene/transcript definitions significantly alter the interpretation of genechip data. Nucleic Acids Res., 33, 2005, e175.
6. Gaujoux, R., Seoighe, C., A flexible R package for nonnegative matrix factorization. BMC Bioinformatics, 11, 2010, 367.
7. Gautier, L., Cope, L., Bolstad, B.M., Irizarry, R.A., affy — analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20 (2004), 307–315.
8. Gevaert, O., MethylMix: an R package for identifying DNA methylation-driven genes. Bioinformatics 31 (2015), 1839–1841.
9. Hovestadt, V., Remke, M., Kool, M., Pietsch, T., Northcott, P.A., Fischer, R., Cavalli, F.M., Ramaswamy, V., Zapatka, M., Reifenberger, G., et al. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol. 125 (2013), 913–916.
10. Hoadley, K.A., Yau, C., Wolf, D.M., Cherniack, A.D., Tamborero, D., Ng, S., Leiserson, M.D., Niu, B., McLellan, M.D., Uzunangelov, V., et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158 (2014), 929–944.
11. Kauffmann, A., Gentleman, R., Huber, W., arrayQualityMetrics – a bioconductor package for quality assessment of microarray data. Bioinformatics 25 (2009), 415–416.
12. Kool, M., Jones, D.T., Jager, N., Northcott, P.A., Pugh, T.J., Hovestadt, V., Piro, R.M., Esparza, L.A., Markant, S.L., Remke, M., et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25 (2014), 393–405.
13. Lafay-Cousin, L., Smith, A., Chi, S.N., Wells, E., Madden, J., Margol, A., Ramaswamy, V., Finlay, J., Taylor, M.D., Dhall, G., et al. Clinical, pathological, and molecular characterization of infant medulloblastomas treated with sequential high-dose chemotherapy. Pediatr. Blood Cancer 63 (2016), 1527–1534.
14. Lex, A., Streit, M., Schulz, H.-J., Partl, C., Schmalstieg, D., Park, P.J., Gehlenborg, N., StratomeX: visual analysis of large-scale heterogeneous genomics data for cancer subtype characterization. Computer Graphics Forum 31 (2012), 1175–1184.
15. Louis, D.N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W.K., Ohgaki, H., Wiestler, O.D., Kleihues, P., Ellison, D.W., The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131 (2016), 803–820.
16. Maksimovic, J., Gordon, L., Oshlack, A., SWAN: subset-quantile within array normalization for Illumina Infinium HumanMethylation450 BeadChips. Genome Biol., 13, 2012, R44.
17. Merico, D., Isserlin, R., Stueker, O., Emili, A., Bader, G.D., Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One, 5, 2010, e13984.
18. Mermel, C.H., Schumacher, S.E., Hill, B., Meyerson, M.L., Beroukhim, R., Getz, G., GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol., 12, 2011, R41.
19. Mo, Q., Wang, S., Seshan, V.E., Olshen, A.B., Schultz, N., Sander, C., Powers, R.S., Ladanyi, M., Shen, R., Pattern discovery and cancer gene identification in integrated cancer genomic data. Proc. Natl. Acad. Sci. USA 110 (2013), 4245–4250.
20. Morrissy, A.S., Garzia, L., Shih, D.J., Zuyderduyn, S., Huang, X., Skowron, P., Remke, M., Cavalli, F.M., Ramaswamy, V., Lindsay, P.E., et al. Divergent clonal selection dominates medulloblastoma at recurrence. Nature 529 (2016), 351–357.
21. Northcott, P.A., Hielscher, T., Dubuc, A., Mack, S., Shih, D., Remke, M., Al-Halabi, H., Albrecht, S., Jabado, N., Eberhart, C.G., et al. Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol. 122 (2011), 231–240.
22. Northcott, P.A., Jones, D.T., Kool, M., Robinson, G.W., Gilbertson, R.J., Cho, Y.J., Pomeroy, S.L., Korshunov, A., Lichter, P., Taylor, M.D., Pfister, S.M., Medulloblastomics: the end of the beginning. Nat. Rev. Cancer 12 (2012), 818–834.
23. Northcott, P.A., Shih, D.J., Peacock, J., Garzia, L., Morrissy, A.S., Zichner, T., Stutz, A.M., Korshunov, A., Reimand, J., Schumacher, S.E., et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488 (2012), 49–56.
24. Northcott, P.A., Lee, C., Zichner, T., Stutz, A.M., Erkek, S., Kawauchi, D., Shih, D.J., Hovestadt, V., Zapatka, M., Sturm, D., et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511 (2014), 428–434.
25. Pei, Y., Liu, K.W., Wang, J., Garancher, A., Tao, R., Esparza, L.A., Maier, D.L., Udaka, Y.T., Murad, N., Morrissy, S., et al. HDAC and PI3K antagonists cooperate to inhibit growth of MYC-driven medulloblastoma. Cancer Cell 29 (2016), 311–323.
26. Ramaswamy, V., Northcott, P.A., Taylor, M.D., FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma. Cancer Genet. 204 (2011), 577–588.
27. Ramaswamy, V., Remke, M., Bouffet, E., Faria, C.C., Perreault, S., Cho, Y.J., Shih, D.J., Luu, B., Dubuc, A.M., Northcott, P.A., et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol. 14 (2013), 1200–1207.
28. Ramaswamy, V., Remke, M., Bouffet, E., Bailey, S., Clifford, S.C., Doz, F., Kool, M., Dufour, C., Vassal, G., Milde, T., et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol. 131 (2016), 821–831.
29. Ramaswamy, V., Remke, M., Adamski, J., Bartels, U., Tabori, U., Wang, X., Huang, A., Hawkins, C., Mabbott, D., Laperriere, N., et al. Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?. Neuro Oncol. 18 (2016), 291–297.
30. Reimand, J., Arak, T., Adler, P., Kolberg, L., Reisberg, S., Peterson, H., Vilo, J., g:Profiler – a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 44 (2016), W83–W89.
31. Remke, M., Hielscher, T., Northcott, P.A., Witt, H., Ryzhova, M., Wittmann, A., Benner, A., von Deimling, A., Scheurlen, W., Perry, A., et al. Adult medulloblastoma comprises three major molecular variants. J. Clin. Oncol. 29 (2011), 2717–2723.
32. Remke, M., Ramaswamy, V., Peacock, J., Shih, D.J., Koelsche, C., Northcott, P.A., Hill, N., Cavalli, F.M., Kool, M., Wang, X., et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol. 126 (2013), 917–929.
33. Rutkowski, S., Cohen, B., Finlay, J., Luksch, R., Ridola, V., Valteau-Couanet, D., Hara, J., Garre, M.-L., Grill, J., Medulloblastoma in young children. Pediatr. Blood Cancer 54 (2010), 635–637.
34. Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B., Ideker, T., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13 (2003), 2498–2504.
35. Shen, R., Olshen, A.B., Ladanyi, M., Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics 25 (2009), 2906–2912.
36. Streit, M., Lex, A., Gratzl, S., Partl, C., Schmalstieg, D., Pfister, H., Park, P.J., Gehlenborg, N., Guided visual exploration of genomic stratifications in cancer. Nat. Methods 11 (2014), 884–885.
37. Sturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.A., Jones, D.T., Konermann, C., Pfaff, E., Tonjes, M., Sill, M., Bender, S., et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22 (2012), 425–437.
38. Taylor, M.D., Northcott, P.A., Korshunov, A., Remke, M., Cho, Y.J., Clifford, S.C., Eberhart, C.G., Parsons, D.W., Rutkowski, S., Gajjar, A., et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123 (2012), 465–472.
39. Thompson, E.M., Hielscher, T., Bouffet, E., Remke, M., Luu, B., Gururangan, S., McLendon, R.E., Bigner, D.D., Lipp, E.S., Perreault, S., et al. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol. 17 (2016), 484–495.
40. Wang, B., Mezlini, A.M., Demir, F., Fiume, M., Tu, Z., Brudno, M., Haibe-Kains, B., Goldenberg, A., Similarity network fusion for aggregating data types on a genomic scale. Nat. Methods 11 (2014), 333–337.
41. Wilkerson, D.M., Hayes, D.N., ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26 (2010), 1572–1573.
42. Zhao, F., Ohgaki, H., Xu, L., Giangaspero, F., Li, C., Li, P., Yang, Z., Wang, B., Wang, X., Wang, Z., et al. Molecular subgroups of adult medulloblastoma: a long-term single-institution study. Neuro Oncol. 18 (2016), 982–990.
43. Zhou, W., Laird, P.W., Shen, H., Comprehensive characterization, annotation and innovative use of Infinium DNA Methylation BeadChip probes. Nucleic Acids Res., 45, 2016, e22.
44. Zhukova, N., Ramaswamy, V., Remke, M., Pfaff, E., Shih, D.J., Martin, D.C., Castelo-Branco, P., Baskin, B., Ray, P.N., Bouffet, E., et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J. Clin. Oncol. 31 (2013), 2927–2935.
45. Zou, H., Hastie, T., Regularization and variable selection via the elastic net. J. R. Stat. Soc. Ser. B 67 (2005), 301–320.